- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
NDST3 Antibody (C-term) Blocking PeptideSynthetic peptide
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| BP17676b | 0.1 mg 400 ul | In Stock | $ 45.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
NDST3 Antibody (C-term) Blocking Peptide - Product info | |
| Primary Accession | O95803 |
| Clone Names | 110617035 |
| Calculated MW | 100902 Da |
NDST3 Antibody (C-term) Blocking Peptide - Additional info | |
| Gene ID 9348 | |
| Format Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
NDST3 Antibody (C-term) Blocking Peptide - Protein Information | |
| Name NDST3 | |
| Synonyms HSST3 | |
| Function Essential bifunctional enzyme that catalyzes both the N- deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. Modifies the GlcNAc-GlcA disaccharide repeating sugar backbone to make N-sulfated heparosan, a prerequisite substrate for later modifications in heparin biosynthesis. Has high deacetylase activity but low sulfotransferase activity | |
| Cellular Location Golgi apparatus membrane; Single-pass type II membrane protein (By similarity) | |
| Tissue Location Expressed in brain, kidney, liver, fetal and adult lung, adult pancreas, placenta, fetal spleen and fetal thymus. Not detected in adult/ fetal heart and skeletal muscle | |
NDST3 Antibody (C-term) Blocking Peptide - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a member of the heparan sulfate/heparinGlcNAc N-deacetylase/ N-sulfotransferase family. The encoded enzymeis a type II transmembrane protein that resides in the Golgiapparatus. This monomeric bifunctional enzyme catalyzes theN-deacetylation and N-sulfation of N-acetylglucosamine residues inheparan sulfate and heparin, which are the initial chemicalmodifications required for the biosynthesis of the functionaloligosaccharide sequences that define the specific ligand bindingactivities of heparan sulfate and heparin.
REFERENCES
Feng, T., et al. Hum. Genet. 128(3):269-280(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Kalsi, G., et al. Hum. Mol. Genet. 19(12):2497-2506(2010)Krenn, E.C., et al. Biochem. Biophys. Res. Commun. 375(3):297-302(2008)Grobe, K., et al. Biochim. Biophys. Acta 1573(3):209-215(2002)
